Cognition Therapeutics, Inc.

NASDAQ:CGTX

0.3724 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -7.842-9.937-7.041-9.151-8.141-6.749-4.726-6.172-5.182-6.625-5.752-3.838-7.339-3.11-1.490.223-1.868-1.791-1.674-2.506
Depreciation & Amortization 0.0710.070.0670.0580.0660.0650.0610.060.060.060.0590.0560.0230.0230.0240.0230.0240.0240.0250.025
Deferred Income Tax 0000-0.8460-0.69100.9434.653001.3310-0.102-1.506-0.0310.1110.096-0.246
Stock Based Compensation 0.5340.8961.1471.1711.0711.0711.0251.1870.9020.7770.8921.0014.9190.0720.0940.0980.1330.1290.0880.125
Change In Working Capital -1.1450.154-0.170.4831.5531.447-0.0561.902-5.9645.784-0.556-0.2072.2380.0330.4630.1080.9960.32-1.2543.005
Accounts Receivables 0.683000.420.3570.755-0.7842.063-1.1440.767-0.501-0.528-1.0951.392-0.237-1.174-0.0620.859-0.1120.219
Change In Inventory 00003.946-1.427-0.456-2.0631.144-0.7670000000000
Change In Accounts Payables 02.3020-0.3770.6030.6721.24-0.075-5.0114.783-0.693-0.1712.443-0.698-0.5330.953-0.650.986-1.0110.311
Other Working Capital -1.828-2.148-0.170.441.1961.447-0.0561.977-0.9531.001-0.207-0.036-0.2050.7310.996-0.8451.646-0.666-0.2432.694
Other Non Cash Items 01.96601.4390.8410.0050.6910.318-0.943-4.653-0.6161.812-1.0710.9320.1010.2820.2660.2460.1970.127
Operating Cash Flow -8.382-6.851-5.997-7.244-5.456-4.161-3.696-2.705-10.184-0.004-5.357-2.9880.101-2.05-0.91-0.772-0.48-0.961-2.5220.53
Investing Activities:
Investments In Property Plant And Equipment -0.0010.003-0.0030-0.03-0.058-0.018-0.041-0.01-0.023-0.004-0.134-0.027000000-0.01
Acquisitions Net 00000000000000000000
Purchases Of Investments 00000000000000000000
Sales Maturities Of Investments 00000000000000000000
Other Investing Activites 0000-0.147000-0.17100-0.134-0.0270000000
Investing Cash Flow -0.0010-0.0030-0.03-0.058-0.018-0.041-0.01-0.023-0.004-0.134-0.027000000-0.01
Financing Activities:
Debt Repayment -0.195-0.185-0.181-0.178-0.179-0.215-0.21-0.207-0.205-0.401-0.396-0.394-0.2680000.4430.1381.3933.837
Common Stock Issued 11.5760.497012.2772.6180.2122.3050.1975.3241.270.0220.30344.217-0.961-1.1558.9560000
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities 00.017-0.022-0.10600005.3471.270.0220.30346.629-0.961-1.1558.9560.00200.007-0.055
Financing Cash Flow 11.3810.329-0.13811.9932.439-0.0032.095-0.015.1420.869-0.374-0.09146.361-0.961-1.1558.9560.4450.1381.43.782
Other Information:
Effect Of Forex Changes On Cash 000000.001-0.0010.0040.004-0.003-0.0030.001-0.0240.021-0.0080-0.0190.052-0.022-0.034
Net Change In Cash 2.998-6.522-6.1384.749-3.047-4.221-1.62-2.752-5.0480.839-5.738-3.21246.411-2.99-2.0738.184-0.054-0.771-1.1444.268
Cash At End Of Period 25.00922.01128.53334.67129.92232.96937.1938.8141.56246.6145.77151.50954.7218.3111.313.3735.1895.2436.0147.158